In the present study, we evaluated the expression of Bax and Bcl-2 genes in hepatocellular carcinoma to investigate the regulatory effect of FEGCG and MPI on the Bcl-2 family. The gene discussed is BCL2; the disease is hepatocellular carcinoma.